Sumatriptan + naproxen

Trade Name: 
Suvexx
Manufacturer/Distributor: 
Aralez Pharmaceuticals Canada Inc.
Classification: 
Serotonin receptor agonist + NSAID
ATC Class: 
N02CC - selective 5HT1-receptor agonists
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2020/02/26
Date Marketed in Canada (yyyy/mm/dd): 
2020/07/24
Presentation: 
Tablet - sumpatriptan 85 mg, naproxen 500 mg. DIN: 02496305
Comments: 
For acute treatment of migraine attacks with or without aura. Not for prophylactic use.
Source: 
Product monograph